Ocular Therapeutix Statistics Share Statistics Ocular Therapeutix has 174M
shares outstanding. The number of shares has increased by 10.67%
in one year.
Shares Outstanding 174M Shares Change (YoY) 10.67% Shares Change (QoQ) 9.22% Owned by Institutions (%) 90.99% Shares Floating 145.24M Failed to Deliver (FTD) Shares 1,591 FTD / Avg. Volume 0.07%
Short Selling Information The latest short interest is 15.28M, so 8.78% of the outstanding
shares have been sold short.
Short Interest 15.28M Short % of Shares Out 8.78% Short % of Float 8.82% Short Ratio (days to cover) 5.58
Valuation Ratios The PE ratio is -6.98 and the forward
PE ratio is -7.63.
Ocular Therapeutix's PEG ratio is
-0.59.
PE Ratio -6.98 Forward PE -7.63 PS Ratio 21.21 Forward PS 30.6 PB Ratio 4.29 P/FCF Ratio -9.94 PEG Ratio -0.59
Financial Ratio History Enterprise Valuation Currently the Enterprise Value (EV) is not available for Ocular Therapeutix.
EV / Sales n/a EV / EBITDA n/a EV / EBIT n/a EV / FCF n/a
Financial Position The company has a current ratio of 10.66,
with a Debt / Equity ratio of 0.24.
Current Ratio 10.66 Quick Ratio 10.59 Debt / Equity 0.24 Debt / EBITDA -0.43 Debt / FCF -0.56 Interest Coverage -12.65
Financial Efficiency Return on Equity is n/a and Return on Invested Capital is n/a.
Return on Equity n/a Return on Assets n/a Return on Invested Capital n/a Revenue Per Employee $232.57K Profits Per Employee $-706.23K Employee Count 274 Asset Turnover 0.14 Inventory Turnover 1.85
Taxes Income Tax n/a Effective Tax Rate 0%
Stock Price Statistics The stock price has increased by 15.96% in the
last 52 weeks. The beta is 1.44, so Ocular Therapeutix's
price volatility has been higher than the market average.
Beta 1.44 52-Week Price Change 15.96% 50-Day Moving Average 12.3 200-Day Moving Average 9.2 Relative Strength Index (RSI) 41.25 Average Volume (20 Days) 2,441,903
Income Statement In the last 12 months, Ocular Therapeutix had revenue of 63.72M
and earned -193.51M
in profits. Earnings per share was -1.22.
Revenue 63.72M Gross Profit 58.1M Operating Income -171.78M Net Income -193.51M EBITDA -176.14M EBIT -179.93M Earnings Per Share (EPS) -1.22
Full Income Statement Balance Sheet The company has 392.1M in cash and 75.78M in
debt, giving a net cash position of 316.32M.
Cash & Cash Equivalents 392.1M Total Debt 75.78M Net Cash 316.32M Retained Earnings -891.08M Total Assets 451.33M Working Capital 390.44M
Full Balance Sheet Cash Flow In the last 12 months, operating cash flow was -134.68M
and capital expenditures -1.29M, giving a free cash flow of -135.97M.
Operating Cash Flow -134.68M Capital Expenditures -1.29M Free Cash Flow -135.97M FCF Per Share -0.86
Full Cash Flow Statement Margins Gross margin is 91.17%, with operating and profit margins of -269.57% and -303.67%.
Gross Margin 91.17% Operating Margin -269.57% Pretax Margin -303.67% Profit Margin -303.67% EBITDA Margin -276.42% EBIT Margin -269.57% FCF Margin -213.37%
